Faron Pharmaceuticals Oy (LON:FARN – Get Free Report) shares crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 41.31 and traded as high as GBX 42. Faron Pharmaceuticals Oy shares last traded at GBX 40.11, with a volume of 8,219 shares trading hands.
Faron Pharmaceuticals Oy Stock Performance
The firm has a market capitalization of £81.38 million, a price-to-earnings ratio of -1.82 and a beta of 1.12. The company has a 50-day moving average price of GBX 41.31 and a 200-day moving average price of GBX 49.81. The company has a quick ratio of 1.09, a current ratio of 0.84 and a debt-to-equity ratio of -133.35.
About Faron Pharmaceuticals Oy
Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.
See Also
- Five stocks we like better than Faron Pharmaceuticals Oy
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
- 3 Low-P/E Stocks That Look Cheap as the S&P 500 Trades Near Record Highs
- Travel + Leisure Goes Big—Is It Ready to Rally?
- 2 Biotech Stocks Shaping Up for Major Breakouts
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.
